Serpin Pharma
PrivateLast Round
Grant
Oct 7, 2024
Total Funding Raised
$5.05M
Momentum Score
50 /100
Company Overview
Serpin Pharma is a clinical-stage biopharmaceutical company that develops first-in-class immunoregulatory therapies for inflammation-driven diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Fashion & Beauty
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Serpin Pharma Comps
Public and private peers based on sector, stage, and business model.
Serpin Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 7, 2024 | ||||
| Grant | Jan 24, 2024 | ||||
| Grant | Sep 20, 2022 | ||||
| Grant | Jun 17, 2021 | ||||
| Grant | Sep 14, 2016 |
Serpin Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| BIRD Foundation | Grant |
| Virginia Catalyst | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors increased 51% MoM, reaching 972.
- May 4, 2025
Monthly visitors increased 82% MoM, reaching 1K.
Serpin Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Serpin Pharma's valuation, stock price, and market status.
